Skip to content
MedCompare

Sofosbuvir

Also known as Sovaldi (us), MyHep (india)

Hepatitis & Antivirals
Infections
Save $25,900/mo
331× cheaper

Sofosbuvir is used to treat certain types of chronic hepatitis C (an ongoing viral infection that damages the liver) in adults. Sofosbuvir is in a class of antiviral medications called nucleotide polymerase inhibitors.

United States
$25,979
per month
India
$78
per month
You save
$25,900
99.70% cheaper in India
81 US scripts/yr$2.1M potential annual savings$2.1M US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC22H29FN3O9P

SMILES: C[C@@H](C(=O)OC(C)C)N[P@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3

Compare the price
US price$25,979per month
India price$78per month
You save$25,90099.70% less

Based on 30 EAs per month. US $865.96 vs India $2.62 per EA.

Total over 1 periodSave $25,900$25,979 → $78
Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Medicine savings over 6 months
$155,401
Estimated travel cost
− $2,300
Net savings after travel
$153,101

Even after travel, you could come out ahead by about $153,101.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Sofosbuvir is filled about 81 times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$2.1M
If sourced from India
$6.4K
Potential annual savings
$2.1M
−100%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.